Novartis AG (NVS) stock
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$159.13−1.07 (-0.67%)
Close on Nov 17, 2026Market cap $303.64BP/E 22.3Yield –
Novartis pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Novartis's pe ratio was 22.8× on Nov 10, 2026, against 22.2× a year earlier. Over the last 5 years it ranged from 7.2× to 33.1×, with a median of 20.7×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 22.8× | −0.7 |
| 2025 | Dec 31, 2025 | 23.5× | +9.8 |
| 2024 | Dec 31, 2024 | 13.7× | −18.1 |
| 2023 | Dec 29, 2023 | 31.9× | +23.3 |
| 2022 | Dec 30, 2022 | 8.5× | −16.3 |
| 2021 | Dec 31, 2021 | 24.8× | +6.2 |
| 2020 | Dec 31, 2020 | 18.7× | +1.1 |
| 2019 | Dec 31, 2019 | 17.6× | −8.8 |
| 2018 | Dec 31, 2018 | 26.4× | −3.6 |
| 2017 | Dec 29, 2017 | 30.0× | +20.0 |
| 2016 | Dec 30, 2016 | 10.0× | – |
See a number that looks wrong?